3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Cholangiocarcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Neoplasm Metastasis
2
Carcinoma, Non-Small-Cell Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Urothelial Bladder Carcinoma
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thymoma
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Pharyngeal Neoplasms
1
Oropharyngeal Neoplasms
1
Oligometastatic Prostate Cancer
1
Mouth Neoplasms
1
Melanoma
1
Lung Diseases
1
Locally Advanced Pancreatic Cancer
1
Locally Advanced Cervical Cancer
1
Liver Neoplasms
1
Liposarcoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Interventions
Cisplatin
43
Radiotherapy
27
Radiotherapy, Intensity-Modulated
24
Radiation
16
Carboplatin
14
Surveys and Questionnaires
13
Magnetic Resonance Spectroscopy
13
Cetuximab
11
Surgical Procedures, Operative
10
pembrolizumab
9
Specimen Handling
8
Chemoradiotherapy
8
Drug Therapy
7
Docetaxel
7
Biopsy
7
1,2-diaminocyclohexaneplatinum II citrate
7
Platinum
6
Paclitaxel
6
Fluorouracil
6
durvalumab
5
X-Rays
5
Observation
5
Blood Specimen Collection
5
Standard of Care
4
Nivolumab
4
Immunohistochemistry
4
Celecoxib
4
Taxes
3
Neck Dissection
3
Liquid Biopsy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Oropharyngeal Neoplasms
×
zimberelimab
×
Clear all
NCT04892875
2023-11-30
PANTHEoN
Vanderbilt-Ingram Cancer Center
Phase 1
Withdrawn